Increasing survivors of anthracycline-related cardiomyopathy with breast cancer in trastuzumab era: thirty-one-year trends in a Japanese Community
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Increasing survivors of anthracycline-related cardiomyopathy with breast cancer in trastuzumab era: thirty-one-year trends in a Japanese Community ; volume:31 ; number:6 ; day:13 ; month:8 ; year:2024 ; pages:1080-1091 ; date:11.2024
Breast cancer ; 31, Heft 6 (13.8.2024), 1080-1091, 11.2024
- Creator
-
Watanabe, Mitsuhiro
Fujiki, Shinya
Okura, Yuji
Toshikawa, Chie
Ikarashi, Mayuko
Kanbayashi, Chizuko
Kaneko, Koji
Kikuchi, Akira
Sakata, Eiko
Tsuchida, Keiichi
Ozaki, Kazuyuki
Moro, Kazuki
Kubota, Naoki
Kashimura, Takeshi
Moriyama, Masato
Sato, Nobuaki
Tanabe, Naohito
Koyama, Yu
Wakai, Toshifumi
Saijo, Yasuo
Inomata, Takayuki
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12282-024-01623-0
- URN
-
urn:nbn:de:101:1-2501072122073.089654052043
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Watanabe, Mitsuhiro
- Fujiki, Shinya
- Okura, Yuji
- Toshikawa, Chie
- Ikarashi, Mayuko
- Kanbayashi, Chizuko
- Kaneko, Koji
- Kikuchi, Akira
- Sakata, Eiko
- Tsuchida, Keiichi
- Ozaki, Kazuyuki
- Moro, Kazuki
- Kubota, Naoki
- Kashimura, Takeshi
- Moriyama, Masato
- Sato, Nobuaki
- Tanabe, Naohito
- Koyama, Yu
- Wakai, Toshifumi
- Saijo, Yasuo
- Inomata, Takayuki
- SpringerLink (Online service)
Other Objects (12)
Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
Correction: Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
Myeloperoxidase is a critical mediator of anthracycline-induced cardiomyopathy
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
Electrocardiograms for cardiomyopathy risk stratification in children with anthracycline exposure
Molecular pathogenetic mechanisms and new therapeutic perspectives in anthracycline-induced cardiomyopathy
Pharmacodynamic modeling of cardiac biomarkers in breast cancer patients treated with anthracycline and trastuzumab regimens
Extracellular matrix remodeling in animal models of anthracycline-induced cardiomyopathy: a meta-analysis
Anthracycline-induced hypertension in pediatric cancer survivors: unveiling the long-term cardiovascular risks
Resting and exercise arterial dysfunction in anthracycline-treated adult survivors of childhood cancers
Early markers of cardiovascular injury in childhood leukaemia survivors treated with anthracycline chemotherapy
Delayed contrast enhancement cardiac magnetic resonance imaging in trastuzumab induced cardiomyopathy
Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
Correction: Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
Myeloperoxidase is a critical mediator of anthracycline-induced cardiomyopathy
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
Electrocardiograms for cardiomyopathy risk stratification in children with anthracycline exposure
Molecular pathogenetic mechanisms and new therapeutic perspectives in anthracycline-induced cardiomyopathy
Pharmacodynamic modeling of cardiac biomarkers in breast cancer patients treated with anthracycline and trastuzumab regimens
Extracellular matrix remodeling in animal models of anthracycline-induced cardiomyopathy: a meta-analysis
Anthracycline-induced hypertension in pediatric cancer survivors: unveiling the long-term cardiovascular risks
Resting and exercise arterial dysfunction in anthracycline-treated adult survivors of childhood cancers
Early markers of cardiovascular injury in childhood leukaemia survivors treated with anthracycline chemotherapy
Delayed contrast enhancement cardiac magnetic resonance imaging in trastuzumab induced cardiomyopathy
Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
Correction: Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
Myeloperoxidase is a critical mediator of anthracycline-induced cardiomyopathy
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
Electrocardiograms for cardiomyopathy risk stratification in children with anthracycline exposure
Molecular pathogenetic mechanisms and new therapeutic perspectives in anthracycline-induced cardiomyopathy
Pharmacodynamic modeling of cardiac biomarkers in breast cancer patients treated with anthracycline and trastuzumab regimens
Extracellular matrix remodeling in animal models of anthracycline-induced cardiomyopathy: a meta-analysis
Anthracycline-induced hypertension in pediatric cancer survivors: unveiling the long-term cardiovascular risks
Resting and exercise arterial dysfunction in anthracycline-treated adult survivors of childhood cancers
Early markers of cardiovascular injury in childhood leukaemia survivors treated with anthracycline chemotherapy